Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-blockers Combined With Neoadjuvant Immunochemotherapy Significantly Improve Pathological Remission in Locally Advanced Gastric Cancer: a Multicenter Controlled Study Based on Hypertensive Patients

NCT07622693 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT07622693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07622693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-blockers Combined With Neoadjuvant Immunochemotherapy Significantly Improve Pathological Remission in Locally Advanced Gastric Cancer: a Multicenter Controlled Study Based on Hypertensive Patients
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
May 10, 2026
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (gc)